PARP1 and Cerebral ischemia: The anti-hemorrhagic effect of PJ34 and the finding that rt-PA increases the activation of the PARP enzyme after cerebral ischemia suggest that PJ34 could be used as an adjunctive treatment to improve the safety of thrombolysis in acute ischemic stroke.